STICE et al. V. STICE et al. V. STRELCHENKO et al. V. HENSEN et al. - Page 8





                                          (d) culturing said cybrid so as to generate an embryo comprising                                             
                                                   embryonic cells; and                                                                                
                                          (e) transferring said embryo of step (d) or a recloned embryo of                                             
                                                   said embryo of step (d) into the uterus of a host animal for                                        
                                                   developing said animal.                                                                             
                                 107. The method of claim [106], wherein said cells are reprogrammed by                                                
                                          cultivation in a culture medium.'                                                                            
                         Strelchenko Application 09/357,445, Paper 2, p. 7.                                                                            
                         B. Comparison of Strelchenko's precritical date claims and the Stice 577                                                      
                             claims                                                                                                                    
                F 46. Slice's 557 claims specify that the donor cell is "a proliferating somatic cell which has been                                   
                         expanded in culture." Paper 7, Appendix (unpaginated).                                                                        
                F 47. Strelchenko's precritical date claims 48, 106 and 107 specify that the donor cell is a                                           
                         totipotent cell. Strelchenko Application 09/357,445, Paper I ( specification), p. 96; Paper                                   
                         2, p. 7.                                                                                                                      
                F 48. Thus, the Stice 577 claims and Strelchenko Claims 48,106 and 107 differinnaming the cell                                         
                         used as the donor cell in nuclear transfer.                                                                                   
                                 1. "Totipotent cells"                                                                                                 
                F 49. The meaning of totipotency to a person having ordinary skill in the art is the ability or                                        
                         capacity of certain cells to differentiate into any type of cell and thus form a new organism                                 
                         or regenerate any part of an organism; e.g., a fertilized ovum, or a small excised portion of                                 
                         a Planaria, which is capable of regenerating a complete new organism.'                                                        
                F 50. Strelchenko's specification expressly defines "totipotent" as follows:                                                           
                                          Ile term "totipotent" as used herein refers to a cell that gives rise to                                     
                                 all of the cells in a developing cell mass, such as an embryo, fetus, and                                             
                                 animal. In preferred embodiments, the term "totipotent" also refers to a cell                                         

                                 Strelchenko Claim 107 as it appears in the preliminary amendment filed July 20, 2000, actually                        
                depends on Claim 50, a claim which was cancelled by the very amendment which added Claims 106 and 107.                                 
                Strelchenko characterizes the reference to Claim 50 as a typographical error and says that Claim 107 should have been                  
                dependant upon Claim 106. Paper 50, p. 11, $ 102, n.2. For the purpose of this decision only, we adopt that                            
                characterization.                                                                                                                      
                         3 Stedman's Medical Dictionary, 27' Ed., Lippincott Williams & Wilkins, Philidelphia, 2000; King et                           
                al., A Dictionary of Genetics Oxford University Press, New York, 1997; Paper 20, p. 8.                                                 
                                                                       -8-                                                                             








Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  Next 

Last modified: November 3, 2007